SCHOTT Pharma AG & Co. KGaA (1SXP) — Financial Flexibility Index
SCHOTT Pharma AG & Co. KGaA (1SXP) has a Financial Flexibility Index of 0.22x as of September 2024. Free cash flow of €140.66 Million (operating CF €75.97 Million minus capex €64.68 Million) represents 0% of total liabilities (€650.00 Million). Also explore 1SXP net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SCHOTT Pharma AG & Co. KGaA Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for SCHOTT Pharma AG & Co. KGaA across 5 annual periods. Check financial resilience of SCHOTT Pharma AG & Co. KGaA to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for SCHOTT Pharma AG & Co. KGaA (2020–2024)
Year-by-year free cash flow to debt coverage for SCHOTT Pharma AG & Co. KGaA. For the full company profile including market capitalisation, see 1SXP stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.57x | €370.62 Million | €225.33 Million | €650.00 Million | ▼ -13.9% |
| 2023 | 0.66x | €357.18 Million | €181.65 Million | €539.65 Million | ▼ -3.6% |
| 2022 | 0.69x | €334.81 Million | €182.12 Million | €487.46 Million | ▼ -4.6% |
| 2021 | 0.72x | €230.84 Million | €132.21 Million | €320.48 Million | ▲ +6.5% |
| 2020 | 0.68x | €189.71 Million | €104.40 Million | €280.36 Million | — |